Back to companies

SAM CHUN DANG PHARM CO. LTD

000250KRKRX

삼천당제약

Revenue
₩210.9bn
FY2024
Operating income
₩2.6bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)